[1]
Chu DT,Hautecoeur P,Santoro JD, Jacques Jean Lhermitte and Lhermitte's sign. Multiple sclerosis (Houndmills, Basingstoke, England). 2018 Dec 20
[PubMed PMID: 30570397]
[2]
Oh J,Vidal-Jordana A,Montalban X, Multiple sclerosis: clinical aspects. Current opinion in neurology. 2018 Dec
[PubMed PMID: 30300239]
Level 3 (low-level) evidence
[3]
The Relationship Between Preoperative Clinical Presentation and Quantitative Magnetic Resonance Imaging Features in Patients With Degenerative Cervical Myelopathy., Nouri A,Tetreault L,Dalzell K,Zamorano JJ,Fehlings MG,, Neurosurgery, 2017 Jan 1
[PubMed PMID: 27607403]
[4]
Lhermitte Sign as a Presenting Symptom of Thoracic Spinal Pathology: A Case Study., Hills A,Al-Hakim M,, Case reports in neurological medicine, 2015
[PubMed PMID: 26339515]
Level 3 (low-level) evidence
[5]
Lhermitte's Sign: The Current Status., Khare S,Seth D,, Annals of Indian Academy of Neurology, 2015 Apr-Jun
[PubMed PMID: 26019410]
[6]
Al-Araji AH,Oger J, Reappraisal of Lhermitte's sign in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). 2005 Aug
[PubMed PMID: 16042221]
[7]
Multiple sclerosis: a primary care perspective., Saguil A,Kane S,Farnell E,, American family physician, 2014 Nov 1
[PubMed PMID: 25368924]
Level 3 (low-level) evidence
[8]
Ependymal cyst presenting with lhermitte sign., Franceschini PR,Worm PV,, Global spine journal, 2014 Jun
[PubMed PMID: 25072004]
[9]
Khan N,Smith MT, Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology. 2014 Feb
[PubMed PMID: 24234347]
[10]
Multifocal central nervous system demyelination and Lhermitte's phenomenon secondary to combination chemotherapy for chronic lymphocytic leukaemia., Hafner J,Kumar K,Mulligan S,Ng K,, Journal of the neurological sciences, 2014 Mar 15
[PubMed PMID: 24468536]
[11]
Rae-Grant AD. Unusual symptoms and syndromes in multiple sclerosis. Continuum (Minneapolis, Minn.). 2013 Aug:19(4 Multiple Sclerosis):992-1006. doi: 10.1212/01.CON.0000433287.30715.07. Epub
[PubMed PMID: 23917097]
[12]
Solaro C,Brichetto G,Amato MP,Cocco E,Colombo B,D'Aleo G,Gasperini C,Ghezzi A,Martinelli V,Milanese C,Patti F,Trojano M,Verdun E,Mancardi GL, The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology. 2004 Sep 14
[PubMed PMID: 15365151]
Level 2 (mid-level) evidence
[13]
Beckmann Y,Özakbaş S,Bülbül NG,Kösehasanoğulları G,Seçil Y,Bulut O,İncesu TK,Tokuçoğlu F,Ertekin C, Reassessment of Lhermitte's sign in multiple sclerosis. Acta neurologica Belgica. 2015 Dec
[PubMed PMID: 25841671]
[14]
Kanchandani R,Howe JG, Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature. Journal of neurology, neurosurgery, and psychiatry. 1982 Apr
[PubMed PMID: 7077340]
Level 3 (low-level) evidence
[15]
Uchihara T,Furukawa T,Tsukagoshi H, Compression of brachial plexus as a diagnostic test of cervical cord lesion. Spine. 1994 Oct 1
[PubMed PMID: 7809749]
[16]
Etemadifar M,Mehrbod N,Dehghani L,Golabbakhsh A,Fereidan-Esfahani M,Akbari M,Nasr Z, Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica. Iranian journal of neurology. 2014
[PubMed PMID: 24800049]
[17]
Nurmikko TJ,Gupta S,Maclver K, Multiple sclerosis-related central pain disorders. Current pain and headache reports. 2010 Jun
[PubMed PMID: 20425191]
[18]
Physiopathology of symptoms and signs in multiple sclerosis., Sá MJ,, Arquivos de neuro-psiquiatria, 2012 Sep
[PubMed PMID: 22990733]
[19]
Kempster PA,Rollinson RD, The Lhermitte phenomenon: variant forms and their significance. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2008 Apr
[PubMed PMID: 18280165]
[20]
Ekbom K, Carbamazepine: A Symptomatic Treatment of the Paresthesiae Associated with Lhermitte's Sign. Annals of Indian Academy of Neurology. 2017 Apr-Jun;
[PubMed PMID: 28615912]
[21]
Truini A,Galeotti F,Cruccu G, Treating pain in multiple sclerosis. Expert opinion on pharmacotherapy. 2011 Oct
[PubMed PMID: 21916786]
Level 3 (low-level) evidence
[22]
Sandyk R,Dann LC, Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields. The International journal of neuroscience. 1995 Apr;
[PubMed PMID: 7628912]
[23]
Yakovlev AE,Parmentier AM, Resolution of Lhermitte's sign with spinal cord stimulation. Pain medicine (Malden, Mass.). 2014 Jan;
[PubMed PMID: 23945019]
[24]
Utilization behavior: clinical manifestations and neurological mechanisms., Archibald SJ,Mateer CA,Kerns KA,, Neuropsychology review, 2001 Sep
[PubMed PMID: 11795839]
[25]
[Lhermitte's sign in three oncological patients]., Porta-Etessam J,Martínez-Salio A,Berbel A,Balsalobre-Aznar J,Esteban J,Benito-León J,Ruiz J,, Revista de neurologia, 2000 Apr 1-15
[PubMed PMID: 10859744]
[26]
Reeves RR,Pinkofsky HB, Lhermitte's sign in paroxetine withdrawal. Journal of clinical psychopharmacology. 1996 Oct;
[PubMed PMID: 8889917]
[30]
Neuropathy following abuse of nitrous oxide., Layzer RB,Fishman RA,Schafer JA,, Neurology, 1978 May
[PubMed PMID: 205816]